# Study of Nitazoxanide in the Treatment of Amebiasis in Children

> **NCT00366730** · PHASE3 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 50 (—)

## Conditions studied

- Amebiasis

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT00366730
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366730, "Study of Nitazoxanide in the Treatment of Amebiasis in Children". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00366730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*